La AEMPS informa del riesgo de sobredosis accidental de paracetamol con soluciones orales pediátricas

Is price associated with the quality of medicines? Evidence from active pharmaceutical ingredient testing in Nigeria

FDA Eliminates Major Barrier to Using Real-World Evidence in Drug and Device Application Reviews

Contraceptive Tied to Higher Brain Tumor Risk in Women

A 24-year pharmacovigilance study on sex differences in adverse drug reactions to antidepressant drugs

Medical Product Alert N°7/2025: Falsified IBRANCE (palbociclib)

Leveraging the Lanham Act for anti-counterfeiting: A case study of Gilead Sciences' successful civil-to-criminal enforcement strategy in the US pharmaceutical market

Blockchain and Artificial Intelligence in Pharmaceutical Supply Chain Traceability: A Systematic Review

Evaluation of performance measures in predictive artificial intelligence models to support medical decisions: overview and guidance

The impact of artificial intelligence-driven decision support on uncertain antimicrobial prescribing: a randomised, multimethod study

WHO and the European Commission expand partnership to combat antimicrobial resistance

Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) on vaccines and autism

Precision pharmacovigilance integrates genomics and real world evidence to overcome drug safety barriers

Diseases are not treated with words, but with medicines. Setting up galenic laboratories in Africa

Performance of the Self‐Controlled Case Series With Active Comparators for Drug Safety Signal Detection Using the Clinical Practice Research Datalink (CPRD)

A Patient Needs a Drug. They Have Their Own Ideas. What Now?

Towards interprofessional medication safety risk management: a qualitative interview study for physicians in primary and secondary care

Exposing Vulnerabilities in Counterfeit Prevention Systems Utilizing Physically Unclonable Surface Features

Evaluating and Optimizing Machine Learning Models to Predict Drug Side Effects

Recent Advances on Thermochromic Inks for Security Applications

Disproportionality and time-to-onset analyses of drug-induced weight gain using the Japanese Adverse Drug Event Report database

Improving Pharmacovigilance via Systematic GASS Screening and Interdisciplinary Collaboration in the Outpatient Setting

Real world based on FAERS database: To explore the mining and analysis of adverse pregnancy events related to drug exposure

Comparative Real-World Safety Profiles of Six Selective Serotonin Reuptake Inhibitors: A Global Pharmacovigilance Analysis

Pharmacovigilance assessment of adverse events following yellow fever vaccination: Disproportionality analysis of VAERS reports, 2015–2025

Assessment of Pharmacovigilance Practices in Primary Healthcare Facilities in Nasarawa State, Nigeria

Enhancing Medication Safety with LLMs

Safety of Herbal Medicine in the Postpartum Period: A Hospital-Based Single-Arm, Prospective Observational Study (SAFEHERE-PC)

Role of Metabolites in Drug-Drug Interactions

Placebo in controlled clinical trials

Engagement and Awareness in the Age of Memes

Spain’s Rise in Off-Label Doxycycline Use for Sexually Transmitted Infections

ISMP Announces New Medication Safety Best Practices

Spain’s Rise in Off-Label Doxycycline Use for Sexually Transmitted Infections

ISMP Announces New Medication Safety Best Practices

New Medication Safety Standards strengthens Australia's response to preventable medicines harm

Burnout, depression, and medication errors among family physicians

Why We Should Defend the Consumer Product Safety Commission

Medical Product Alert N°6/2025: Falsified SIMULECT (basiliximab) for injection

Postmarket Drug Safety−Related Actions Before and After the US Food and Drug Administration Amendments Act